Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Palivizumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Palivizumab 100mg inj vials
0503050A0AAAAAA
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 100mg/1ml solution for injection vials
0503050A0AAADAD
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 50mg inj vials
0503050A0AAABAB
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 50mg/0.5ml solution for injection vials
0503050A0AAACAC
|
Palivizumab | Palivizumab | Infections | No data available |
|
Synagis 100mg inj vials
0503050A0BBAAAA
|
Synagis | Palivizumab | Infections | No data available |
|
Synagis 100mg/1ml solution for injection vials
0503050A0BBADAD
|
Synagis | Palivizumab | Infections | No data available |
|
Synagis 50mg inj vials
0503050A0BBABAB
|
Synagis | Palivizumab | Infections | No data available |
|
Synagis 50mg/0.5ml solution for injection vials
0503050A0BBACAC
|
Synagis | Palivizumab | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.